Viewing Study NCT00555594


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-25 @ 6:56 PM
Study NCT ID: NCT00555594
Status: COMPLETED
Last Update Posted: 2024-08-01
First Post: 2007-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
Sponsor: Asociación para Evitar la Ceguera en México
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Cornea2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View